Rozenn N Lemaitre Selected Research

Fatty Acids (Saturated Fatty Acids)

11/2022	The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: a Mendelian randomization study.
1/2022	Very long-chain saturated fatty acids and diabetes and cardiovascular disease.
1/2022	Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE).
1/2021	Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes.
1/2021	Assessment of Plasma Phospholipid Very-Long-Chain Saturated Fatty Acid Levels and Healthy Aging.
1/2020	Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
1/2020	Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
11/2019	Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
11/2019	Potential Interplay between Dietary Saturated Fats and Genetic Variants of the NLRP3 Inflammasome to Modulate Insulin Resistance and Diabetes Risk: Insights from a Meta-Analysis of 19 005 Individuals.
1/2019	Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rozenn N Lemaitre Research Topics

Disease

21	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 04/2002
18	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2010
16	Coronary Disease (Coronary Heart Disease) 12/2021 - 06/2002
15	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 05/2006
14	Myocardial Infarction 08/2011 - 04/2002
13	Heart Failure 01/2022 - 05/2003
10	Ischemic Stroke 01/2019 - 06/2002
10	Stroke (Strokes) 01/2018 - 04/2002
10	Atherosclerosis 10/2017 - 12/2008
7	Insulin Resistance 01/2021 - 12/2010
7	Hypertension (High Blood Pressure) 01/2010 - 04/2002
6	Atrial Fibrillation 01/2022 - 03/2012
5	Heart Diseases (Heart Disease) 06/2018 - 12/2003
4	Inflammation (Inflammations) 01/2021 - 06/2014
4	Heart Arrest (Cardiac Arrest) 01/2018 - 02/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 02/2007 - 10/2004
3	Diabetes Mellitus 01/2019 - 09/2013
2	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2010
2	Infarction (Infarctions) 05/2020 - 10/2013
2	Metabolic Diseases (Metabolic Disease) 12/2019 - 01/2018
2	Obesity 01/2019 - 06/2013
2	Genetic Risk Score 01/2019 - 11/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 03/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018 - 04/2010
2	Cardiotoxicity 01/2018 - 04/2013
2	Ventricular Fibrillation 01/2016 - 05/2006
2	Sudden Death 04/2012 - 06/2003
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2006 - 02/2003
2	Hypercholesterolemia 06/2005 - 06/2002
2	Hemorrhagic Stroke 10/2003 - 09/2002
1	Weight Loss (Weight Reduction) 01/2021
1	Pulmonary Edema 05/2020
1	Reperfusion Injury 05/2020
1	Fibrosis (Cirrhosis) 05/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020

Drug/Important Bio-Agent (IBA)

36	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 02/2003
21	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2002
17	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019 - 02/2003
14	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 02/2003
10	Trans Fatty AcidsIBA 01/2022 - 02/2002
9	LipidsIBA 12/2021 - 10/2004
9	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2011
7	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021 - 02/2003
6	Estrogens (Estrogen)FDA Link 12/2006 - 09/2002
5	CeramidesIBA 01/2022 - 01/2018
5	AcidsIBA 04/2021 - 08/2011
5	Insulin (Novolin)FDA Link 01/2021 - 11/2015
5	Docosahexaenoic AcidsIBA 01/2021 - 02/2003
5	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 05/2020 - 06/2008
5	palmitoleic acidIBA 10/2018 - 12/2010
5	Hormones (Hormone)IBA 01/2018 - 09/2002
5	Triglycerides (Triacylglycerol)IBA 01/2015 - 10/2004
4	SphingomyelinsIBA 01/2022 - 01/2018
4	Biological ProductsIBA 01/2022 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 02/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 06/2007
4	Eicosapentaenoic AcidIBA 10/2017 - 02/2003
4	CholesterolIBA 12/2010 - 06/2002
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2021
3	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 04/2012
3	CarbohydratesIBA 12/2019 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 06/2002
3	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2019 - 01/2011
3	EnzymesIBA 01/2019 - 02/2007
3	Linoleic Acid (Linoleate)IBA 01/2019 - 02/2002
3	HDL CholesterolIBA 12/2010 - 06/2002
3	DiureticsIBA 01/2010 - 04/2002
3	Conjugated (USP) Estrogens (Premarin)FDA Link 12/2006 - 10/2004
3	Progestins (Progestagens)IBA 02/2006 - 09/2002
2	SphingolipidsIBA 01/2021 - 01/2018
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2020 - 06/2008
2	FatsIBA 11/2019 - 01/2018
2	fibroblast growth factor 21IBA 01/2019 - 01/2018
2	Arachidonic Acid (Vitamin F)IBA 01/2019 - 12/2017
2	SugarsIBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2010
2	docosapentaenoic acidIBA 10/2017 - 03/2012
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2015 - 08/2011
2	Plant Oils (Vegetable Oils)IBA 01/2013 - 02/2003
2	Antihypertensive Agents (Antihypertensives)IBA 01/2010 - 04/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2010 - 12/2003
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2009 - 12/2003
1	lignoceric acid (tetracosanoic acid)IBA 01/2022
1	arachidic acidIBA 01/2022
1	behenic acid (docosanoic acid)IBA 01/2022
1	Serum AlbuminIBA 01/2021
1	gamma-butyrobetaine (butyrobetaine)IBA 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	Betaine (C.B.B.)FDA Link 01/2021
1	crotonic acid betaineIBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	NLR ProteinsIBA 11/2019

Therapy/Procedure

9	Therapeutics 03/2008 - 04/2002
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2021 - 06/2002
2	Resuscitation 01/2016 - 08/2012